Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis

Heart and Vessels

Volumn 30, Issue 6, 2015, Pages 779-788

  Sano, Makoto ^a   Satoh, Hiroshi ^a   Suwa, Kenichiro ^a   Nobuhara, Mamoru ^a   Saitoh, Takeji ^a   Saotome, Masao ^a   Urushida, Tsuyoshi ^a   Katoh, Hideki ^a   Shimoyama, Kumiko ^a   Suzuki, Daisuke ^a   Ogawa, Noriyoshi ^a   Takehara, Yasuo ^a   Sakahara, Harumi ^a   Hayashi, Hideharu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac function; Conduction disturbance; Electrocardiography; Late gadolinium enhancement; Systemic scleroderma

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CENTROMERE ANTIBODY; GADODIAMIDE; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; GADOLINIUM; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DISEASE DURATION; ECG ABNORMALITY; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE ASYNERGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; JAPANESE (PEOPLE); MALE; MIDDLE AGED; NEW YORK HEART ASSOCIATION CLASS; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; BLOOD; CARDIAC MUSCLE; CARDIOMYOPATHIES; COMPLICATION; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHIES; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SCLERODERMA, SYSTEMIC; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 84947495888     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-014-0539-y     Document Type: Article

References (43)

1. de Groote P, Gressin V, Hachulla E, Carpentier P, Guillevin L, Kahan A, Cabane J, Frances C, Lamblin N, Diot E, Patat F, Sibilia J, Petit H, Cracowski JL, Clerson P, Humbert M (2008) Evaluation of cardiac abnormalities by doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 67:31–36
2. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, Riemekasten G, Cozzi F, Beretta L, Derk CT, Komocsi A, Farge D, Balbir A, Riccieri V, Distler O, Chiala A, Papa ND, Simic KP, Ghio M, Stamenkovic B, Rednic S, Host N, Pellerito R, Zegers E, Kahan A, Walker UA, Matucci-Cerinic M (2010) Prevalence and factors associated with left ventricular dysfunction in the EULAR scleroderma trial and research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 69:218–221
3. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y (2008) Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 58:1803–1809
4. D’Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 46:428–440
5. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM (1976) Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 53:483–490
6. Kahan A, Allanore Y (2006) Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford) 45(Suppl 4):14–17
7. Kanno H, Segawa T, Miura Y, Miyata M, Yoshida A, Nakamura M, Sawai T (2011) Systemic sclerosis presented as congestive heart failure: an autopsy case. Mod Rheumatol 21:423–427
8. Nagai Y, Yamanaka M, Hashimoto C, Nakano A, Hasegawa A, Tanaka Y, Yokoo H, Nakazato Y, Ishikawa O (2007) Autopsy case of systemic sclerosis with severe pulmonary hypertension. J Dermatol 34:769–772
9. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10
10. Allanore Y, Wahbi K, Borderie D, Weber S, Kahan A, Meune C (2009) N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? Ann Rheum Dis 68:1885–1889
11. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453
12. Saji M, Takamisawa I, Iguchi N, Takayama M (2013) Cardiac MRI detected septal and lateral myocardial infarction by alcohol septal ablation through the intermediate artery. Heart Vessel 28:672–676
13. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, Gialafos EJ, Moyssakis I, Moutsopoulos HM (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56:3827–3836
14. Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, Hatron PY, Beregi JP, Hachulla E (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68:1878–1884
15. Di Cesare E, Battisti S, Di Sibio A, Cipriani P, Giacomelli R, Liakouli V, Ruscitti P, Masciocchi C (2013) Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). Eur J Radiol 82:e268–e273
16. Takehara K, Satoh S. Kuwana M (2007) Guideline for the diagnosis of systemic sclerosis (in Japanese). The Japanese Ministry of Health Labor and Welfare, 1–32, 2007
17. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
18. Matoh F, Satoh H, Shiraki K, Saitoh T, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H (2007) Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. J Card Fail 13:372–379
19. Feng D, Glockner J, Kim K, Martinez M, Syed IS, Araoz P, Breen J, Espinosa RE, Sundt T, Schaff HV, Oh JK (2011) Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation 124:1830–1837
20. Fernandes F, Ramires FJ, Arteaga E, Ianni BM, Bonfa ES, Mady C (2003) Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9:311–317
21. Liangos O, Neure L, Kuhl U, Pauschinger M, Sieper J, Distler A, Schwimmbeck PL, Braun J (2000) The possible role of myocardial biopsy in systemic sclerosis. Rheumatology (Oxford) 39:674–679
22. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, Sheppard MN, Poole-Wilson PA, Pennell DJ (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977–1985
23. De Cobelli F, Pieroni M, Esposito A, Chimenti C, Belloni E, Mellone R, Canu T, Perseghin G, Gaudio C, Maseri A, Frustaci A, Del Maschio A (2006) Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. J Am Coll Cardiol 47:1649–1654
24. Hen Y, Iguchi N, Machida H, Takada K, Utanohara Y, Sumiyoshi T (2013) High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Heart Vessels 28:742–749
25. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC (2010) Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 122:138–144
26. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, Peacock AJ (2005) Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 26:1993–1999
27. McCann GP, Gan CT, Beek AM, Niessen HW, Vonk Noordegraaf A, van Rossum AC (2007) Extent of mri delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension. Am J Roentgenol 188:349–355
28. Freed BH, Gomberg-Maitland M, Chandra S, Mor-Avi V, Rich S, Archer SL, Jamison EB Jr, Lang RM, Patel AR (2012) Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension. J Cardiovasc Magn Reson 14:11
29. Pfisterer ME, Battler A, Zaret BL (1985) Range of normal values for left and right ventricular ejection fraction at rest and during exercise assessed by radionuclide angiocardiography. Eur Heart J 6:647–655
30. Hesselstrand R, Scheja A, Wuttge DM, Arheden H, Ugander M (2011) Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. Scand J Rheumatol 40:133–138
31. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567
32. Bogaert J, Kalantzi M, Rademakers FE, Dymarkowski S, Janssens S (2007) Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 17:2572–2580
33. Satoh H, Matoh F, Shiraki K, Saitoh T, Odagiri K, Saotome M, Urushida T, Katoh H, Takehara Y, Sakahara H, Hayashi H (2009) Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy. J Card Fail 15:419–427
34. Lehrke S, Lossnitzer D, Schob M, Steen H, Merten C, Kemmling H, Pribe R, Ehlermann P, Zugck C, Korosoglou G, Giannitsis E, Katus HA (2011) Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97:727–732
35. Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, Judd RM, Kim RJ (2009) Detection of myocardial damage in patients with sarcoidosis. Circulation 120:1969–1977
36. Zemrak F, Petersen SE (2011) Late gadolinium enhancement cmr predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis 54:215–229
37. Steen VD, Powell DL, Medsger TA Jr (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31:196–203
38. Steen VD (2005) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35:35–42
39. Follansbee WP, Curtiss EI, Rahko PS, Medsger TA Jr, Lavine SJ, Owenes GR, Steen VD (1985) The elctrocardiogram in systemic sclerosis (scleroderma). Study of 102 consecutive cases with functional correlations and review of the literature. Am J Med 79:183–192
40. Poanta L, Dadu R, Tiboc C, Rednic S, Dumitrascu D (2009) Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med 20:378–382
41. D’Andrea A, Stisi S, Bellissimo S, Vigorito F, Scotto di Uccio F, Tozzi N, Moscato F, Pezzullo E, Calabro R, Scherillo M (2005) Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by doppler myocardial and strain rate imaging. Eur J Echocardiogr 6:407–418
42. Spethmann S, Dreger H, Schattke S, Riemekasten G, Borges AC, Baumann G, Knebel F (2012) Two-dimensional speckle tracking of the left ventricle in patients with systemic sclerosis for an early detection of myocardial involvement. Eur Heart J Cardiovasc Imaging 13:863–870
43. Plastiras SC, Toumanidis ST (2012) Systemic sclerosis: the heart of the matter. Hellenic J Cardiol 53:287–300